Levothyroxine sodium CAPSULES Not Covered by Part D Plans

HeyMOE Tip

Don’t panic if you see “Not Covered” next to levothyroxine sodium capsules — you’re not missing something. Every 2026 Part D plan excludes levothyroxine sodium capsules. However, levothyroxine sodium tablets ARE covered.
Switching to a tablet of levothyroxine sodium Finasteride could save you hundreds.

What’s Happening

Early HeyMOE results show that no stand-alone Medicare Part D drug plans will cover levothyroxine sodium capsules in 2026.

That means if you take levothyroxine sodium capsules (of any doseage), your Part D plan will not pay anything toward the cost of that medication next year — and since it’s not covered, your spending will not count toward your Part D out-of-pocket limit.

In other words, you’d be responsible for the full retail cost of levothyroxine sodium capsules.

What This Means for You

If you currently take levothyroxine sodium capsules, you’ll have two options for 2026:

1. Pay Out of Pocket

The cash price of levothyroxine sodium capsules averages $150 per refill.

2. Switch to a tablet version of levothyroxine sodium.

levothyroxine sodium tablets are included on 2026 Part D formularies.

Talk to your prescribing doctor before December 7 to see whether switching to a tablet makes sense for you.

What HeyMOE Is Doing

HeyMOE automatically checks your medication list to determine whether a drug is covered under any Part D plan and, if not, your account is flagged for manual review.

If levothyroxine sodium capsules is an uncovered medication on your list, we get in touch with you with the information in this support article.